Tango Therapeutics, Inc. (TNGX)
TNGX price $26.88 +1.63 +6.46%
- Ticker
- TNGX
- Price
- $26.88
- Change
- +1.63 +6.46%
- Market cap
- $4.53B
- P/E
- -29.71
- Forward P/E
- 30.01
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 64
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions…